Gallagher Neil — SEC Form 4 filings
SEC reporting owner CIK 1972849. 7 Form 4 filings on record with FilingPulse; latest filed 2026-06-25.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-02-09 to 2026-06-25. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 4,618 shares, $71,597 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 10.
- Largest priced transaction: sale of 4,618 shares @ $15.50 ($71,597) in Syndax Pharmaceuticals Inc, filed 2025-02-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Syndax Pharmaceuticals Inc (SNDX) | President, Head of R&D | 3 | — | 1 leg · 4,618 sh · $71,597 | 6 |
| Foghorn Therapeutics Inc. (FHTX) | Director | 2 | — | — | 2 |
| Zymeworks Inc. (ZYME) | Director | 2 | — | — | 2 |
Form 4 filings — Gallagher Neil
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-25 | 4 | Foghorn Therapeutics Inc. (FHTX) | Grant/award (A): 28,000 (derivative) @ $4.08 | EDGAR |
| 2025-05-02 | 4 | Foghorn Therapeutics Inc. (FHTX) | Grant/award (A): 50,000 (derivative) @ $4.16 | EDGAR |
| 2025-02-12 | 4 | Syndax Pharmaceuticals Inc (SNDX) | Sale (S): 4,618 @ $15.50 | EDGAR |
| 2025-02-07 | 4 | Syndax Pharmaceuticals Inc (SNDX) | Grant/award (A): 18,500 @ $0 · Grant/award (A): 23,400 @ $0 · Grant/award (A): 110,500 (derivative) @ $14.65 | EDGAR |
| 2024-12-12 | 4 | Zymeworks Inc. (ZYME) | Grant/award (A): 31,000 (derivative) @ $0 | EDGAR |
| 2024-04-02 | 4 | Zymeworks Inc. (ZYME) | Grant/award (A): 74,000 (derivative) @ $0 | EDGAR |
| 2024-02-09 | 4 | Syndax Pharmaceuticals Inc (SNDX) | Grant/award (A): 34,688 @ $0 · Grant/award (A): 13,125 @ $0 · Grant/award (A): 69,375 (derivative) @ $22.28 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1972849 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →